 IRVINE, Calif., Feb. 23, 2021 GLOBE NEWSWIRE -- ClearPoint Neuro, Inc. Nasdaq: CLPT the Company, a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the closing of its previously disclosed public offering of common stock. The total number of shares of common stock sold was 2,127,660, composed of 1,850,140 shares of common stock initially offered at a public offering price of 23.50 per share and an additional 277,520 shares of common stock sold pursuant to the exercise of the underwriters option to purchase additional shares at the price of 22.09 per share. The net proceeds to the Company from the offering, after deducting underwriting discounts and commissions and estimated offering expenses, are approximately 46.8 million. The Company will use the net proceeds from the offering to fund product development and research and development activities and the remainder for working capital and general corporate purposes. 